Outcomes of catheter ablation for ventr tachycardia in structural heart disease: a meta-analysis and quality appraisal of trials
We examined the effectiveness of catheter ablation (CA) for treating ventricular tachycardia (VT) in patients with structural heart disease, particularly those facing recurrent implantable cardioverter defibrillator shocks or unable to tolerate medications by analysing several randomized controlled trials. The findings suggest that while CA may not significantly reduce overall mortality, it can lead to fewer recurrences of VT and hospitalizations related to cardiovascular problems.
Authors
- Pier D. Lambiase (ORCID: https://orcid.org/0000-0002-9055-9267)
- Gabriella Captur (ORCID: https://orcid.org/0000-0002-5662-0642)
- Debbie Falconer (ORCID: https://orcid.org/0000-0003-1057-3155)
- Richard J. Schilling (ORCID: https://orcid.org/0000-0002-0621-8241)
- Ahmed Salih (ORCID: https://orcid.org/0000-0002-6470-3325)
- Rui Providência (ORCID: https://orcid.org/0000-0001-9141-9883)
- Νικόλαος Παπαγεωργίου (ORCID: https://orcid.org/0000-0002-2063-2510)
Institutions
- St Bartholomew's Hospital (GB)
- The Royal Free Hospital (GB)
- Department of Science and Technology (IN)
- NIHR Imperial Biomedical Research Centre (GB)
- The London College (GB)
- University College London (GB)
- Imperial College London (GB)
Publication Details
- Journal
- European Heart Journal Open
- Published
- 2025-12-11
- DOI
- https://doi.org/10.1093/ehjopen/oeaf171
- Primary Topic
- Cardiac Arrhythmias and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Government of the United Kingdom
- UK Research and Innovation
- National Institute for Health and Care Research
- British Heart Foundation
- HORIZON EUROPE Framework Programme